Evaluation of the Toxicity of 5-Aryl-2-Aminoimidazole-Based Biofilm Inhibitors against Eukaryotic Cell Lines, Bone Cells and the Nematode Caenorhabditis elegans

Microwave-assisted one-pot synthesis and anti-biofilm activity of 2-amino-1H-imidazole/triazole conjugates

(2014) Hans Steenackers et al.   ORGANIC & BIOMOLECULAR CHEMISTRY

2-aminothiophene-3-carboxylic acid ester derivatives as novel highly selective cytostatic agents

(2013) J. Balzarini et al.   INVESTIGATIONAL NEW DRUGS

Evaluation of the toxicity of 2-aminoimidazole antibiofilm agents using both cellular and model organism systems

(2012) Sean D. Stowe et al.   DRUG AND CHEMICAL TOXICOLOGY

Design, Synthesis, Antiviral, and Cytotoxic Evaluation of Novel Phosphonylated 1,2,3-Triazoles as Acyclic Nucleotide Analogues

(2012) Iwona E. Głowacka et al.   NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS

Structure–activity relationship of 2-hydroxy-2-aryl-2,3-dihydro-imidazo[1,2-a]pyrimidinium salts and 2N-substituted 4(5)-aryl-2-amino-1H-imidazoles as inhibitors of biofilm formation by Salmonella Typhimurium and Pseudomonas aeruginosa

(2011) Hans P.L. Steenackers et al.   BIOORGANIC & MEDICINAL CHEMISTRY

Anti-Biofilm Compounds Derived from Marine Sponges

(2011) Sean D. Stowe et al.   Marine Drugs

Concise and Diversity-Oriented Route toward Polysubstituted 2-Aminoimidazole Alkaloids and Their Analogues

(2010) Denis S. Ermolat'ev et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Molecular mechanisms of compounds affecting bacterial biofilm formation and dispersal

(2010) Paolo Landini et al.   APPLIED MICROBIOLOGY AND BIOTECHNOLOGY

Non-mammalian animal models to study infectious disease: worms or fly fishing?

(2010) David O’Callaghan et al.   CURRENT OPINION IN MICROBIOLOGY

Pseudomonas aeruginosabiofilm infections in cystic fibrosis: insights into pathogenic processes and treatment strategies

(2010) Daniel J Hassett et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Interference of Pseudomonas aeruginosa signalling and biofilm formation for infection control

(2010) Thomas Bjarnsholt et al.   EXPERT REVIEWS IN MOLECULAR MEDICINE

Biofilms in chronic infections – a matter of opportunity – monospecies biofilms in multispecies infections

(2010) Mette Burmølle et al.   FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY

The immune system vs.Pseudomonas aeruginosabiofilms

(2010) Peter Østrup Jensen et al.   FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY

Antibiotic resistance of bacterial biofilms

(2010) Niels Høiby et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Structure−Activity Relationship of 4(5)-Aryl-2-amino-1H-imidazoles,N1-Substituted 2-Aminoimidazoles and Imidazo[1,2-a]pyrimidinium Salts as Inhibitors of Biofilm Formation bySalmonellaTyphimurium andPseudomonas aeruginosa

(2010) Hans P. L. Steenackers et al.   JOURNAL OF MEDICINAL CHEMISTRY

Evolving concepts in biofilm infections

(2009) Luanne Hall-Stoodley et al.   CELLULAR MICROBIOLOGY

Ability of Recombinant Human Bone Morphogenetic Protein 2 to Enhance Bone Healing in the Presence of Tobramycin: Evaluation in a Rat Segmental Defect Model

(2009) Vaida Glatt et al.   JOURNAL OF ORTHOPAEDIC TRAUMA

Pseudomonas aeruginosabiofilms in the respiratory tract of cystic fibrosis patients

(2009) Thomas Bjarnsholt et al.   PEDIATRIC PULMONOLOGY

Control of bacterial biofilms with marine alkaloid derivatives

(2008) Robert W. Huigens III et al.   Molecular BioSystems

Caenorhabditis elegans: An Emerging Model in Biomedical and Environmental Toxicology

(2008) Maxwell C. K. Leung et al.   TOXICOLOGICAL SCIENCES